Retirement Wealth Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.48K Sell
352
-118
-25% -$3.09K ﹤0.01% 250
2026
Q1
$13.2K Buy
470
+186
+65% +$4.95K 0.01% 180
2025
Q4
$7.08K Sell
284
-67
-19% -$1.69K ﹤0.01% 263
2025
Q3
$8.95K Sell
351
-711
-67% -$17.5K 0.01% 239
2025
Q2
$25.7K Buy
1,062
+6
+0.6% +$140 0.02% 130
2025
Q1
$26.8K Buy
1,056
+85
+9% +$2.22K 0.02% 111
2024
Q4
$25.9K Buy
+971
New +$26.3K 0.02% 120

Other funds holding PFE

Retirement Wealth Solutions's PFE Position: Q2 2026 in Review

Retirement Wealth Solutions reduced its Pfizer (PFE) stake by 25% in Q2 2026, selling an estimated $3.09K and leaving 352 shares worth $8.48K. The position accounts for ﹤0.01% of the portfolio, ranked #250.

Retirement Wealth Solutions first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.8K in Q1 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Retirement Wealth Solutions held 352 shares of Pfizer worth $8.48K as of Q2 2026.
  • Retirement Wealth Solutions sold 118 Pfizer shares in Q2 2026, an estimated $3.09K.
  • Pfizer made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #250 holding.
  • Retirement Wealth Solutions first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Retirement Wealth Solutions's Pfizer position peaked at $26.8K in Q1 2025.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.